Dr. Walter Kernan is a Professor of Internal Medicine at Yale University School of Medicine. Dr. Kernan was educated at Harvard College and Dartmouth Medical School and then completed his internship and residency at Johns Hopkins Hospital. After fellowship training at Yale he joined the Yale faculty in the Section of General Internal Medicine. In addition to practicing general internal medicine, Dr. Kernan’s work has included educational administration and clinical research on topics at the interface of internal medicine and cerebrovascular disease. He has a particular interest in stroke and was a speaker at the Canadian Stroke Congress where I met him.
He is currently the principal investigator for a multi-institutional trial funded by the National Institutes of Neurological Disorders and Stroke to test the effectiveness of PPAR gamma agonist therapy, compared with placebo, for prevention of recurrent stroke and myocardial infarctoin among non-diabetic persons with a recent ischemic stroke or transient ischemic attack and insulin resistance.
EDUCATION & TRAINING
MD Dartmouth College (1984)
BA Harvard College (1978)
Fellow Yale University School of Medicine
Resident Johns Hopkins Hospital
Board Certification AB of Internal Medicine, Internal Medicine (1987)